Suppr超能文献

动物和人类在病理及异常生理状态下的药物代谢。

Drug metabolism under pathological and abnormal physiological states in animals and man.

作者信息

Kato R

出版信息

Xenobiotica. 1977 Jan-Feb;7(1-2):25-92. doi: 10.3109/00498257709036242.

Abstract

The activity of microsomal drug-metabolizing enzymes is altered by several pathological or abnormal physiological states, such as changes in nutritional status, liver, heart or kidney diseases, hormonal disturbances, pregnancy, tumour-bearing state, adjuvant arthritis, changes in reticuloendothelial system and environmental factors (stress, irradiation, heavy metals). The activities of other metabolic pathways, such as glucuronidation, sulphate conjugation, acetylation and alcohol oxidation are generally affected to lesser extents. Rats are most commonly used in drug metabolism studies, and it is important to know that the activity of most of the microsomal drug-metabolizing enzymes is higher in males than in females through androgen action which is readily impaire drug-metabolizing enzymes in male rats are thus manifested by two mechanisms; one is by impairment of androgen action and the other is by depression of the basic enzymic activity. Therefore, those effects of pathological states, observed only in male rats but not in females, are generally not seen in other species of animals, including man. The effects of starvation, hyperthyroidism, adrenal insufficiency, diabetes and morphine administration are cases where changes in metabolism are due solely to impairment of androgen action. In other pathological cases, those drug-metabolizing enzymes showing sex differences are depressed more markedly in male rats than those showing no clear sex difference. The author therefore recommends the use of female rats in the evaluation of the effects of pathological states on hepatic microsomal drug-metabolizing enzymes. Generally, changes in activity of the hepatic enzymes reflect closely the changes in the rates of drug metabolism in vivo. However, the protein-binding of drugs, hepatic blood flow and renal function are also known to affect the rate of drug metabolism and excretion in vivo, and therefore changes of these factors in pathological states should also be taken into consideration.

摘要

微粒体药物代谢酶的活性会因多种病理或异常生理状态而改变,如营养状况变化、肝脏、心脏或肾脏疾病、激素紊乱、妊娠、荷瘤状态、佐剂性关节炎、网状内皮系统变化以及环境因素(应激、辐射、重金属)。其他代谢途径的活性,如葡萄糖醛酸化、硫酸结合、乙酰化和酒精氧化,通常受到的影响较小。大鼠是药物代谢研究中最常用的动物,需要注意的是,由于雄激素的作用,大多数微粒体药物代谢酶在雄性大鼠中的活性高于雌性大鼠,雄性大鼠中的药物代谢酶受损有两种机制:一种是雄激素作用受损,另一种是基础酶活性降低。因此,仅在雄性大鼠而非雌性大鼠中观察到的病理状态的这些影响,在包括人类在内的其他动物物种中通常未见。饥饿、甲状腺功能亢进、肾上腺功能不全、糖尿病和给予吗啡的影响,是代谢变化仅归因于雄激素作用受损的情况。在其他病理情况下,与无明显性别差异的药物代谢酶相比,雄性大鼠中表现出性别差异的那些药物代谢酶受到更明显抑制。因此,作者建议在评估病理状态对肝脏微粒体药物代谢酶的影响时使用雌性大鼠。一般来说,肝脏酶活性的变化密切反映体内药物代谢速率的变化。然而,药物的蛋白结合、肝血流量和肾功能也已知会影响体内药物代谢和排泄速率,因此在病理状态下这些因素的变化也应予以考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验